NCT00769171 - Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) | Biotech Hunter

Enrollment

364

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2007

Conditions

Infection, Intra-abdominal

Interventions

DRUG

Avelox (Moxifloxacin, BAY12-8039)

Moxifloxacin 400 mg every 24 h

DRUG

Ceftriaxone + Metronidazole

Ceftriaxone 2 g every 24 h and Metronidazole 500 mg every 12 h

Trial Locations (25)

813

Kaoshiung

20400

Terengganu

40161

Bandung

70428

Tainan City

93400

Kuching

100044

Beijing

100050

Beijing

100730

Beijing

200032

Shanghai

200127

Shanghai

200233

Shanghai

300000

Tianjin

310003

Hangzhou

610041

Chengdu

Unknown

Nanjing

Beijing

Shanghai

Hong Kong

Shatin

Taipei

480-130

Uijeongbu-si

405-760

Incheon

137-701

Seoul

150-713

Seoul

420-717

Seoul